Research Papers

25 of 148 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Trichoscopic, oral, and periungual fold findings as activity and damage markers in dermatomyositis patients and their c…
Salgueiro C; Poblete MJ; Robles-Silva C; Abarzúa Á; Vera-Kellet C.
Arch Dermatol Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The patient perspective on vaccine uptake in adults with psoriasis and eczema.
Noe MH; Archila M; Barbieri JS; Goldman N; Lopez CG; Mostaghimi A; Scherer AM; Tan AJ; Perez-Chada LM; Asgari MM; Gelfand JM.
Arch Dermatol Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The role of insomnia in the vulnerability to depressive and anxiety symptoms in atopic dermatitis adult patients.
Salfi F; Amicucci G; Ferrara M; Tempesta D; De Berardinis A; Chiricozzi A; Peris K; Fargnoli MC; Esposito M.
Arch Dermatol Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Characterization of online support group resources for patients with dermatologic conditions.
Kaundinya T; El-Behaedi S; Bilimoria S; Choi JN.
Arch Dermatol Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Time to treatment and complexity of Mohs micrographic surgery.
Salman R; Daly C; Dani A; Eseonu A; Bibee K; Scott JF.
Arch Dermatol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
The utility of augmented teledermatology to improve dermatologist diagnosis of cellulitis: a cross-sectional study.
Creadore A; Manjaly P; Tkachenko E; Li DG; Kaffenberger B; Shinkai K; Rosenbach M; Joyce C; Mostaghimi A.
Arch Dermatol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Intralesional Candida albicans antigen versus intralesional zinc sulfate in treatment of cutaneous warts.
Youssef EMK; Eissa MAA; Bakr RM.
Arch Dermatol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Platycodin D inhibits the proliferation and migration of hypertrophic scar-derived fibroblasts and promotes apoptosis t…
Yu Z; Li Y; Fu R; Xue Y; Zhao D; Han D.
Arch Dermatol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Racial disparities in dermatology.
Narla S; Heath CR; Alexis A; Silverberg JI.
Arch Dermatol Res (Unknown)
Published: 2022
2/6 Transparent
Lichen planus after COVID-19 infection and vaccination.
Zou H; Daveluy S.
Arch Dermatol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Understanding downstream service profitability generated by dermatology faculty in an academic medical center: a key dr…
Pearlman RL; Nahar VK; Sisson WT; Clark J; Ferris TS; Black WH; Brodell RT.
Arch Dermatol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Risk factors for the development of acne in healthcare workers during the COVID-19 pandemic.
Dani A; Eseonu A; Bibee K.
Arch Dermatol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Microneedling combined with botulinum toxin-A versus microneedling combined with platelet-rich plasma in treatment of a…
Albalat W; Ghonemy S; Saleh A; Elradi M.
Arch Dermatol Res (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Utilization of teledermatology services for dermatological diagnoses during the COVID-19 pandemic.
He A; Ti Kim T; Nguyen KD.
Arch Dermatol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Urea versus fractional Er:YAG laser pretreatment of methylene blue photodynamic therapy in the treatment of moderate to…
Alberdi E; Gómez C.
Arch Dermatol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Basal cell carcinomas in organ transplant recipients versus the general population: clinicopathologic study.
Pandeya N; Huang N; Jiyad Z; Plasmeijer EI; Way M; Isbel N; Campbell S; Chambers DC; Hopkins P; Soyer HP; Whiteman DC; Olsen CM; Green AC.
Arch Dermatol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
The efficacy and safety of intralesional Candida vaccine versus topical diphencyproprobenone in immunotherapy of verruc…
El-Komy MHM; Shamma SG; Bedair NI.
Arch Dermatol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Gender differences in isotretinoin prescriptions during the COVID-19 pandemic at a U.S. academic medical center.
Duan GY; Ruiz de Luzuriaga AM.
Arch Dermatol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Role of streptococcal infection in the etiopathogenesis of pityriasis lichenoides chronica and the therapeutic efficacy…
Elbendary A; Youssef R; Abdel-Halim MRE; Abdel Halim D; El Sharkawy DA; Alfishawy M; Gad MA; Gad A; Elmasry MF.
Arch Dermatol Res (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Innovating on innovation training with the Virtual Magic Wand (VMW) program: a qualitative study.
Davis Rebekah A; Lee Kachiu C; Lee Ivy A; Levin Yakir S; Garibyan L.
Arch Dermatol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Website transparency of dermatology residency programs: a cross-sectional study.
Wyant WA; Elman SA; Nambudiri VE.
Arch Dermatol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Bullous pemphigoid anti-BP180-NC16A autoantibody reactivity in healthy individuals is associated with marked hypovitami…
Tukaj S; Bieber K; Prüßmann W; Prüßmann JN; Schmidt E; Zillikens D; Ludwig RJ; Kasperkiewicz M.
Arch Dermatol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Questionnaire-based epidemiological survey of primary focal hyperhidrosis and survey on current medical management of p…
Fujimoto T; Inose Y; Nakamura H; Kikukawa Y.
Arch Dermatol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Evaluation of vitamin D receptor gene polymorphisms (ApaI and TaqI) as risk factors of vitiligo and predictors of respo…
Youssef YE; Eldegla HEA; Elmekkawy RSM; Gaballah MA.
Arch Dermatol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Improvements and advances in core outcome set methodology: proceedings of the CS-COUSIN & COMFA Joint Meeting.
Dirr MA; Alam M; Apfelbacher C; Drewitz KP; Kang BY; Munblit D; Nekliudov N; Seylanova N.
Arch Dermatol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared